AVENUE THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Avenue Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Avenue Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.16M, a 52.6% decline year-over-year.
  • Avenue Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$11.8M, a 27.7% increase year-over-year.
  • Avenue Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$14.5M, a 80.8% decline from 2022.
  • Avenue Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$8.04M, a 115% decline from 2021.
  • Avenue Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$3.74M, a 28.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.